Characterization of the neutralizing anti-emicizumab antibody in a patient with hemophilia A and inhibitor.

Although the incidence of neutralizing anti-emicizumab antibody is rare, this study highlights the importance of a close monitoring and the need of a simple laboratory assay to promptly detect these antibodies in patients with a history of poor drug efficacy.